Literature DB >> 14632782

Intravenous administration of replication-incompetent adenovirus to rhesus monkeys induces thrombocytopenia by increasing in vivo platelet clearance.

N Wolins1, J Lozier, T L Eggerman, E Jones, E Aguilar-Córdova, J G Vostal.   

Abstract

A replication-incompetent adenovirus vector was administered to rhesus macaques at 1, 3 and 6 x 1012 particles/kg doses to investigate its toxicity. Platelet count decrements of 28%, 82% and 90%, respectively, were observed, with corresponding platelet half-lives of 69.0, 25.2 and 22.2 h (compared with 111 h in untreated animals). The platelet decline was equivalent for all three doses for 8 h, and platelet count recovery began as early as 8 h after infusion for low-dose recipients, or as late as 24 h for the medium and high dose recipients. These observations suggest that thrombocytopenia is a saturable, reversible consumptive process.

Entities:  

Mesh:

Year:  2003        PMID: 14632782     DOI: 10.1046/j.1365-2141.2003.04719.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  29 in total

1.  Intratumoral delivery of CD154 homolog (Ad-ISF35) induces tumor regression: analysis of vector biodistribution, persistence and gene expression.

Authors:  J Melo-Cardenas; M Urquiza; T J Kipps; J E Castro
Journal:  Cancer Gene Ther       Date:  2012-03-09       Impact factor: 5.987

2.  TRIF, and TRIF-interacting TLRs differentially modulate several adenovirus vector-induced immune responses.

Authors:  D M Appledorn; S Patial; S Godbehere; N Parameswaran; A Amalfitano
Journal:  J Innate Immun       Date:  2009-03-04       Impact factor: 7.349

Review 3.  Current strategies and future directions for eluding adenoviral vector immunity.

Authors:  Dinesh S Bangari; Suresh K Mittal
Journal:  Curr Gene Ther       Date:  2006-04       Impact factor: 4.391

4.  Adenovirus-platelet interaction in blood causes virus sequestration to the reticuloendothelial system of the liver.

Authors:  Daniel Stone; Ying Liu; Dmitry Shayakhmetov; Zong-Yi Li; Shaoheng Ni; André Lieber
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

5.  [Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination].

Authors: 
Journal:  Neurologia       Date:  2021-05-06       Impact factor: 3.109

6.  Stimulation of innate immunity by in vivo cyclic di-GMP synthesis using adenovirus.

Authors:  Benjamin J Koestler; Sergey S Seregin; David P W Rastall; Yasser A Aldhamen; Sarah Godbehere; Andrea Amalfitano; Christopher M Waters
Journal:  Clin Vaccine Immunol       Date:  2014-09-17

Review 7.  Adenoviral vector immunity: its implications and circumvention strategies.

Authors:  Yadvinder S Ahi; Dinesh S Bangari; Suresh K Mittal
Journal:  Curr Gene Ther       Date:  2011-08       Impact factor: 4.391

8.  Transient pretreatment with glucocorticoid ablates innate toxicity of systemically delivered adenoviral vectors without reducing efficacy.

Authors:  Sergey S Seregin; Daniel M Appledorn; Aaron J McBride; Nathaniel J Schuldt; Yasser A Aldhamen; Tyler Voss; Junping Wei; Matthew Bujold; William Nance; Sarah Godbehere; Andrea Amalfitano
Journal:  Mol Ther       Date:  2009-01-27       Impact factor: 11.454

9.  Adenoviral p53 gene transfer and gemcitabine in three patients with liver metastases due to advanced pancreatic carcinoma.

Authors:  Gernot W Wolkersdörfer; Christian Thiede; Rainer Fischer; Gerhard Ehninger; Cornelie Haag
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

10.  beta-Arrestins modulate Adenovirus-vector-induced innate immune responses: differential regulation by beta-arrestin-1 and beta-arrestin-2.

Authors:  Sergey S Seregin; Daniel M Appledorn; Sonika Patial; M Bujold; W Nance; S Godbehere; Narayanan Parameswaran; Andrea Amalfitano
Journal:  Virus Res       Date:  2009-11-06       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.